Sézary
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome (NCT04960618) | Memorial Sloan Kettering Cancer Center | 2021-10-01 |
Track Sézary automatically
Every clearance here is in the API, with alerts when new ones post.